Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-126-0 | CAS number: 78-59-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
Upon oral and inhalative administration, isophorone is well absorbed and rapidly distributed through the body of rats and rabbits. Dermal absorptioncan be concluded from the systemic effects in the acute dermal toxicity studies. But in an in vitro dermal absorption study with human skin disks (In Vitro Technologies, Inc., 2006) most of the applied dose of isophorone was recovered in the surface wash at the end of the incubation time. The total amount absorbed was less than 5% even after exposure for 24 hours. While part of the absorbed isophorone is excreted unchanged via urine and exhaled air, metabolites are mainly excreted as glucuronides. The tendency of isophorone to bioaccumulate is very low, since within 96 hours after administration more than 80 % of orally administered isophorone was excreted by rats.
Key value for chemical safety assessment
- Absorption rate - dermal (%):
- 5
Additional information
Absorption
Isophorone is well absorbed via oral and inhalative route (Dutertre-Catella, Thesis Universite Rene Descartes, Paris, 1976). Already 10 minutes after oral administration to 2 rabbits, remarkable isophorone concentrations in the blood were detected. Dermal absorption can be concluded from the systemic effects in the acute dermal toxicity studies (see chapter 7.2.3). But in an in vitro dermal absorption study with human skin disks (In Vitro Technologies, Inc., 2006; see chapter 7.12 ) most of the applied dose of isophorone was recovered in the surface wash at the end of the incubation time. The total amount absorbed was less than 5% even after exposure for 24 hours. The Kp value obtained indicates that isophorone is a moderate to fast penetrant. The amount of isophorone dosed onto the skin disks appeared to simulate an infinite dose under the experimental conditions used in this study. This is inferred from the observations that the total amount absorbed was less than 5% even after exposure for 24 hours and that the amount of isophorone absorbed into the receptor fluid reached a stady state.
Distribution
In male and female rats and rabbits isophorone is rapidly distributed. One hour after a single oral administration of isophorone the highest concentrations were found in the stomach, pancreas, adrenals, spleen and liver of rats and rabbits. After inhalation for 4 hours, the highest concentrations were obtained in the kidney, adrenals, liver, pancreas and brain of rats immidiately after the termination of inhalation (Dutertre-Catella, Thesis Universite Rene Descartes, Paris, 1976). 24 hours after the single oral administration of 500 mg radioactive labeled isophorone/kg to mice and rats, the highest concentrations were found in kidney, liver, lung, spleen and adrenals (Thier, R., 1991). 48 hours after oral administration to male and female rats, only traces of isophorone could be determined in the stomach and no isophorone was measured in the other organs (Dutertre-Catella, Thesis Universite Rene Descartes, Paris, 1976).
Metabolism
After oral application of isophorone, one main metabolite in rats and rabbits is 5,5-dimethyl-1-cyclohexene-3-one-1-carboxylic acid. This metabolite is formed by oxidation of the 3 -methyl group of isophorone and then glucuronidated (Dutertre-Catella et al., 1978; Truhaut et al., 1970). Further metabolites may be formed through hydrogenation at the 1-one or/and 2-ene-position or after further oxidation processes. Dihydroisophorone (3,5,5 -trimethyl-cyclohexanone), isophorol (3,5,5 -trimethyl-cyclohex-2 -en-1-ol), cis- and trans-3,5,5 -trimethyl-cyclohexanol-1, 6 -Oxoisophorone (3,5,5 -trimethyl-2 -cyclohexen-1,6 -dione), 4 -Oxoisophorone (3,5,5 -trimethyl-2 -cyclohexen-1,4 -dione), 4 -hydroxyisophorone (4-hydroxy-3,5,5 -trimethyl-2-cyclohexen-1-one) and
6-hydroxyisophorone (6-hydroxy-3,5,5-trimethyl-2-cyclohexen-1-one) were identified via GC/Kovats indices and GC/MS (Dutertre-Catella et al., 1976; Thier, R., 1991).
Excretion
After inhalativ administration of isophorone to rats for 4 hours, a part of the isophorone was expired unchanged (Dutertre-Catella, 1976). Also in the urine of orally treated rabbits and rats unreacted isophorone could be isolated (Dutertre-Catella et al., 1978; Truhaut et al., 1970; Thier, R., 1991). After single as well as repeated-dose oral administration of isophorone to rats 80 % of radioactivity was excreted within 96 hours. 50 - 65 % were detected in the urine (Thier, R., 1991).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.